Home Coronavirus FDA Set To Approve Coronavirus Booster Shots For Immunocompromised People

FDA Set To Approve Coronavirus Booster Shots For Immunocompromised People


  The Food and Drug Administration on Thursday is expected to authorize extra doses of coronavirus vaccines for patients with weakened immune systems, a move that could mean additional shots will be available for that vulnerable population as soon as this weekend.

The FDA action on the immunocompromised is likely to affect transplant patients who take immune-suppressing drugs to prevent rejection of new organs and others who have diseases, including blood cancers, that damage the immune system.

Making such patients eligible for an extra shot, doctors say, is preferable to having worried patients seek out additional inoculations illicitly — which is already happening. Federal health officials have estimated that about 3 percent of U.S. adults are immunocompromised. They are more likely to become seriously ill from covid-19, experts say.

The timing of the expected action was described by people with knowledge of the process who spoke on the condition of anonymity, because they were not authorized to speak publicly. The Washington Post first reported Friday that action on the shots was imminent.

PLEASE NOTE: The Washington Post is providing this important information about the coronavirus for free. For more free coverage of the coronavirus pandemic, sign up for our Coronavirus Updates newsletter where all stories are free to read.

WashingtonPost.com, excerpt posted on SouthFloridaReporter.com, Aug. 12, 2021